Chen Si, Liu Yan, Wang Yuanyuan, Xue Zhaoping
Department of Colorectal and Anal Surgery.
Department of Spine Surgery.
Onco Targets Ther. 2019 Nov 5;12:9215-9225. doi: 10.2147/OTT.S216718. eCollection 2019.
The aim was to determine the function and molecular mechanism of long non-coding RNA colon cancer associated transcript-1(lncRNA CCAT1) in the development of colorectal cancer (CRC).
CCAT1 mRNA expression levels were determined in CRC tissues and cells using reverse transcription-quantitative polymerase chain reaction. Cell Counting Kit-8 and colony formation assays were used to examine the effects of CCAT1 on the proliferation of CRC cells. Luciferase reporter gene analysis was used to confirm the target gene of microRNA-181b-5p (miR-181b-5p) in CRC cells. Tumor xenografts were subsequently used to investigate the role of CCAT1 in CRC growth in vivo.
The relative mRNA expression levels of CCAT1 were significantly higher in CRC tissues and cell lines compared with the normal tissues or cells. CCAT1 knockdown significantly inhibited CRC cell proliferation in vitro and in vivo. Bioinformatics and luciferase reporter assays showed that miR-181b-5p was a direct target of CCAT1, and the expression of miR-181b-5p was negatively correlated with the expression of CCAT1 in CRC tissues. Furthermore, CCAT1 positively regulated the level of tumor suppressor candidate 3 (TUSC3) by competing with miR-181b-5p in CRC cells.
These data suggested that lncRNA CCAT1 promoted colorectal cancer tumorigenesis via a miR-181b-5p/TUSC3 axis.
本研究旨在确定长链非编码RNA结肠癌相关转录本1(lncRNA CCAT1)在结直肠癌(CRC)发生发展中的作用及分子机制。
采用逆转录-定量聚合酶链反应检测CRC组织和细胞中CCAT1 mRNA表达水平。使用细胞计数试剂盒-8和集落形成实验检测CCAT1对CRC细胞增殖的影响。采用荧光素酶报告基因分析确定CRC细胞中微小RNA-181b-5p(miR-181b-5p)的靶基因。随后通过肿瘤异种移植实验研究CCAT1在体内CRC生长中的作用。
与正常组织或细胞相比,CCAT1在CRC组织和细胞系中的相对mRNA表达水平显著更高。敲低CCAT1可显著抑制体外和体内CRC细胞的增殖。生物信息学和荧光素酶报告实验表明,miR-181b-5p是CCAT1的直接靶标,且在CRC组织中miR-181b-5p的表达与CCAT1的表达呈负相关。此外,在CRC细胞中,CCAT1通过与miR-181b-5p竞争,正向调节肿瘤抑制候选基因3(TUSC3)的水平。
这些数据表明lncRNA CCAT1通过miR-181b-5p/TUSC3轴促进结直肠癌的肿瘤发生。